Patel Sujal M 4
4 · Nautilus Biotechnology, Inc. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
Patel Sujal M
DirectorCEO, President, and Secretary10% Owner
Transactions
- Purchase
Common Stock
2025-09-05$0.67/sh+116,500$78,544→ 10,258,221 total - Purchase
Common Stock
2025-09-08$0.68/sh+83,500$57,031→ 10,341,721 total
Holdings
- 5,280,476(indirect: By LLC)
Common Stock
- 1,814,035(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents the weighted average share price of an aggregate total of 116,500 shares purchased in the price range of $0.6547 to $0.6899 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 83,500 shares purchased in the price range of $0.6581 to $0.7145 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
- [F4]Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.